3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Hyperthermia
20
Sarcoma
7
Uterine Cervical Neoplasms
4
Rectal Neoplasms
4
Prostatic Neoplasms
4
Head and Neck Neoplasms
4
Melanoma
3
Colonic Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Sarcoma, Synovial
1
Sarcoma, Clear Cell
1
Sarcoma, Alveolar Soft Part
1
Salivary Gland Adenoma, Pleomorphic
1
Recurrence
1
Prehypertension
1
Prediabetic State
1
Polycystic Ovary Syndrome
1
Peritoneal Neoplasms
1
Pelvic Pain
1
Oropharyngeal Neoplasms
1
Obesity
1
Neurofibrosarcoma
1
Neoplasms, Radiation-Induced
1
Interventions
Trichloroacetic Acid
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
human papillomavirus vaccine, L1 type 16, 18
2
Vaccines
2
Papillomavirus Vaccines
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Ethanol
2
nanocurcumin
1
hecolin
1
Zinc
1
Vaccination
1
Tuberculin
1
Surgical Procedures, Operative
1
Podophyllin
1
PRA1 protein, Candida albicans
1
Medical Records
1
Measles-Mumps-Rubella Vaccine
1
Lasers, Gas
1
Imiquimod
1
Hepatitis B Vaccines
1
Electrocoagulation
1
Diathermy
1
Cyclophosphamide
1
Curcumin
1
Cryotherapy
1
Cantharidin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Condylomata Acuminata
×
Diathermy
×
Clear all
NCT03289260
2020-09-23
AdAM
Medical University Innsbruck
Phase 3
Unknown
200 enrolled